We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Relationship of Serum Cortisol and Serum Sodium Analyzed

By LabMedica International staff writers
Posted on 19 Jul 2017
Print article
Image: The Advia Centaur XP immunoassay analyzer (Photo courtesy of Siemens Healthcare).
Image: The Advia Centaur XP immunoassay analyzer (Photo courtesy of Siemens Healthcare).
Hyponatremia is the most common electrolyte disorder encountered by the clinical biochemist, and is associated with a significant mortality and hypernatremia is also a risk factor for mortality in critically ill patients.

Adrenal insufficiency is an uncommon cause of hyponatremia, but one that should not be overlooked because an Addisonian crisis, once recognized, can be easily and safely treated with fluid replacement and corticosteroid. Clinical practice guidelines on hyponatremia advise that primary or secondary adrenal insufficiency should always be considered as a potential cause of hyponatremia.

Medical laboratory scientists at the Leeds General Infirmary (Leeds, UK) defined severe hyponatremia as a sodium concentration equal to or less than 120 mmol/L and severe hypernatraemia was defined as a sodium concentration equal to or greater than 150 mmol/L. The reference range for serum cortisol in a morning sample at the Leeds Teaching Hospitals NHS Trust is 150 to 600 nmol/L. Data was gathered on samples where both serum sodium and cortisol that had been requested from the laboratory information management system for 23 months (January 1, 2013, until November 30, 2014).

Serum sodium and cortisol were measured on Advia 1800 or 2400 and Centaur XP analyzers respectively. Analysis of the data from 3,268 patients revealed a trend showing higher cortisol concentrations in patients who were severely hypo- or hypernatremic. The median cortisol concentration for patients with sodium equal to or less than 110 mmol/L was 856 nmol/L, and there was a gradual decrease in cortisol over the sodium range equal to or less than 110 to 150 mmol/L. Patients with sodium equal to or greater than 151 mmol/L had a median cortisol of 725 nmol/L, and 42% of the 978 patients with serum sodium of less than or equal to 120 mmol/L had serum cortisol measured within two weeks, of whom 1.7% were diagnosed with adrenal insufficiency.

The authors concluded that despite the relative rarity of endocrine causes of hyponatremia, adrenal insufficiency should remain an important consideration in the clinical workup of the hypernatremic patient due to the severe consequences of failure to treat with glucocorticoid replacement and volume repletion. The dataset shows rising cortisol in response to hypo- or hypernatremia, in keeping with the stress response to illness. The data show that adrenal insufficiency is a rare cause of hyponatremia, which may be overlooked. The full study will be published in the August 2017 issue of the journal Practical Laboratory Medicine.

Related Links:
Leeds General Infirmary

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Molecular Diagnostics

view channel
Image: The fastGEN BCR::ABL1 Cancer kit offers a way to personalize treatment strategies for leukemia (Photo courtesy of BioVendor MDx)

First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment

The BCR::ABL1 fusion gene plays a key role in the pathogenesis of several blood cancers, particularly chronic myeloid leukemia (CML). This gene results from a chromosomal translocation that causes constitutive... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more